Clinical Trial Update: Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 study comparing AGN-210669 ophthalmic solution with bimatoprost ophthalmic solution in open-angle glaucoma or ocular hypertension; results regarding saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AGN-210669 ophthalmic solution
• Lumigan (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2013-11-06